换一批
换一批There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression.
作者：
主题词
腺癌(Adenocarcinoma);老年人(Aged);抗肿瘤药(Antineoplastic Agents);活组织检查(Biopsy);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);癌, 鳞状细胞(Carcinoma, Squamous Cell);I类磷脂酰肌醇3-激酶类(Class I Phosphatidylinositol 3-Kinases);DNA突变分析(DNA Mutational Analysis);疾病恶化(Disease Progression);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);分子靶向治疗(Molecular Targeted Therapy);试验预期值(Predictive Value of Tests);蛋白激酶抑制剂(Protein Kinase Inhibitors);时间因素(Time Factors);体层摄影术, X线计算机(Tomography, X-Ray Computed);治疗结果(Treatment Outcome);超声检查(Ultrasonography)
DOI
10.1136/jclinpath-2017-204370
PMID
28363898
发布时间
2019-02-21
- 浏览4
Journal of clinical pathology
798-802页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
